DK644388A - Farmaceutiske praeparater indeholdende 3-hydroxy-smoeresyrederivater - Google Patents

Farmaceutiske praeparater indeholdende 3-hydroxy-smoeresyrederivater

Info

Publication number
DK644388A
DK644388A DK644388A DK644388A DK644388A DK 644388 A DK644388 A DK 644388A DK 644388 A DK644388 A DK 644388A DK 644388 A DK644388 A DK 644388A DK 644388 A DK644388 A DK 644388A
Authority
DK
Denmark
Prior art keywords
hydroxy
acid derivatives
pharmaceutical preparations
preparations containing
lubric
Prior art date
Application number
DK644388A
Other languages
English (en)
Other versions
DK168269B1 (da
DK644388D0 (da
Inventor
William Nichels
Oultremont Philippe D
Original Assignee
Solvay
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay filed Critical Solvay
Publication of DK644388D0 publication Critical patent/DK644388D0/da
Publication of DK644388A publication Critical patent/DK644388A/da
Application granted granted Critical
Publication of DK168269B1 publication Critical patent/DK168269B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
DK644388A 1987-11-19 1988-11-18 Farmaceutiske præparater indeholdende 3-hydroxysmøresyrederivater og dialyseopløsning, der er egnet til peritoneal dialyse DK168269B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BE8701314A BE1001209A3 (fr) 1987-11-19 1987-11-19 Compositions pharmaceutiques contenant un derive de l'acide 3-hydroxybutanoique choisi parmi les oligomeres de cet acide et les esters de cet acide ou de ces oligomeres avec du 1,3-butanediol.
BE8701314 1987-11-19

Publications (3)

Publication Number Publication Date
DK644388D0 DK644388D0 (da) 1988-11-18
DK644388A true DK644388A (da) 1989-07-03
DK168269B1 DK168269B1 (da) 1994-03-07

Family

ID=3882973

Family Applications (1)

Application Number Title Priority Date Filing Date
DK644388A DK168269B1 (da) 1987-11-19 1988-11-18 Farmaceutiske præparater indeholdende 3-hydroxysmøresyrederivater og dialyseopløsning, der er egnet til peritoneal dialyse

Country Status (10)

Country Link
US (1) US5112865A (da)
EP (1) EP0316993B1 (da)
JP (1) JPH01160917A (da)
AT (1) ATE65397T1 (da)
BE (1) BE1001209A3 (da)
CA (1) CA1330307C (da)
DE (1) DE3863904D1 (da)
DK (1) DK168269B1 (da)
ES (1) ES2037818T3 (da)
GR (1) GR3002605T3 (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5126373A (en) * 1987-11-19 1992-06-30 Henri Brunengraber Composition for parenteral and oral nutrition
US6323237B1 (en) * 1997-03-17 2001-11-27 Btg International Limited Therapeutic compositions
CN1315473C (zh) * 1997-03-17 2007-05-16 英国技术集团国际有限公司 治疗组合物
US20090253781A1 (en) * 2002-05-24 2009-10-08 Btg International Limited Therapeutic compositions
US6164451A (en) * 1998-03-16 2000-12-26 Trish Mcevoy, Ltd. Cosmetics case
DE19830310A1 (de) * 1998-07-07 2000-01-13 Riedel De Haen Gmbh Verfahren zur Abreicherung des Bromidgehaltes aus einer wäßrigen Bromid enthaltenden Lösung unter Verwendung von Wasserstoffperoxid
DE69922206T2 (de) * 1998-07-22 2005-11-24 Metabolix, Inc., Cambridge Nahrungs- und therapeutische verwendung von hydroxyalkanoat oligomere
US20020077269A1 (en) * 2000-10-27 2002-06-20 Whitehouse Robert S. Alkanoic acid ester monomer compositions and methods of making same
WO2003051813A1 (en) * 2001-12-18 2003-06-26 Metabolix, Inc. Methods of making intermediates from polyhydroxyalkanoates
EP1648952B1 (en) * 2003-06-03 2018-03-07 THE UNITED STATES GOVERNMENT as represented by THE DEPARTMENT OF HEALTH AND HUMAN SERVICES Nutritional supplements and therapeutic compositions comprising (r)-3-hydroxybutyrate derivatives
GB0410266D0 (en) * 2004-05-07 2004-06-09 Ketocytonyx Inc Treatment of apoptosis
EP2240017B1 (en) 2008-01-04 2019-03-13 Oxford University Innovation Limited Ketone bodies and ketone body esters as blood lipid lowering agents
US8642654B2 (en) * 2009-04-16 2014-02-04 Isis Innovation Limited Hydroxybutyrate ester and medical use thereof
JP5773870B2 (ja) * 2008-08-21 2015-09-02 アイシス イノヴェイション リミテッド ヒドロキシ酪酸エステル及びその医学的使用
US9084467B2 (en) 2010-02-11 2015-07-21 Metabolix, Inc. Process for gamma-butyrolactone production
GB201002983D0 (en) 2010-02-22 2010-04-07 Tdeltas Ltd Nutritinal composition
DK2914251T3 (da) 2012-11-05 2019-11-04 Us Health Ketonlegemer til beskyttelse af væv mod beskadigelse som følge af ioniseringsstråling
GB201304467D0 (en) 2013-03-12 2013-04-24 Tdeltas Ltd Compound for use in protecting skin
GB2515603B (en) 2013-03-14 2015-10-14 Isis Innovation Process for producing (R)-3-Hydroxybutyl (R)-3-Hydroxybutyrate
WO2017213999A1 (en) 2016-06-07 2017-12-14 The J. David Gladstone Institutes Medium chain fatty acid esters of beta-hydroxybutyrate and butanediol and compositions and methods for using same
US20180057846A1 (en) 2016-08-30 2018-03-01 KetoneAid Inc. Partially buffered free acid and/or ketone blend for rapid onset ketosis and metabolic therapy
WO2019018683A1 (en) * 2017-07-21 2019-01-24 Buck Institute For Research On Aging BETA-HYDROXYBUTYRATE AND BUTANEDIOL ENANTIOMERS AND METHODS OF USE THEREOF
US11760963B2 (en) 2017-08-23 2023-09-19 KetoneAid Inc. Ketogenic beer and alcoholic beverage mixture containing non-racemic ethyl 3-hydroxybutyrate and/or 1,3 butanediol
WO2019147503A1 (en) 2018-01-25 2019-08-01 Buck Institute For Research On Aging Synthesis of 3-hydroxybutyryl 3-hydroxybutyrate and related compounds
US12396974B2 (en) 2020-03-27 2025-08-26 KetoneAid Ketone ester as a therapeutic treatment of Covid-19 and related viral infections

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2500312C2 (de) * 1975-01-07 1984-01-19 Basf Ag, 6700 Ludwigshafen Verfahren zur Herstellung von Butandiol-(1,3)-3-mono-(3'-hydroxybutyraten)sowie einige dieser Butandiol-(1,3)-3-mono-(3'-hydroxybutyrate)
DE2500310C2 (de) * 1975-01-07 1984-01-19 Basf Ag, 6700 Ludwigshafen Verfahren zur Herstellung von Butandiol-(1,3)-1-mono-(3'-hydroxybutyraten)sowie einige dieser Butandiol-(1,3)-1-mono-(3'-hydroxybutyrate)
FR2486072A1 (fr) 1980-07-03 1982-01-08 Solvay Procede pour la fabrication de l'acide b-hydroxybutyrique et de ses oligocondensats
US4574085A (en) * 1981-05-15 1986-03-04 Baxter Travenol Laboratories, Inc. Method for using dialysis solution containing glycerol
FR2521857B1 (fr) * 1982-02-23 1985-10-31 Solvay Compositions pharmaceutiques contenant de l'acide 3-hydroxybutanoique ou un sel derive de cet acide et sels derives de l'acide 3-hydroxybutanoique et d'une base organique azotee
JPS63502274A (ja) * 1985-12-18 1988-09-01 ビ−チ，リチヤ−ド　エル Ｌ↓−乳酸および／またはピルビン酸アニオンを用いた流体式治療法

Also Published As

Publication number Publication date
BE1001209A3 (fr) 1989-08-22
DK168269B1 (da) 1994-03-07
EP0316993B1 (fr) 1991-07-24
JPH01160917A (ja) 1989-06-23
ATE65397T1 (de) 1991-08-15
EP0316993A1 (fr) 1989-05-24
GR3002605T3 (en) 1993-01-25
ES2037818T3 (es) 1993-07-01
DE3863904D1 (de) 1991-08-29
DK644388D0 (da) 1988-11-18
US5112865A (en) 1992-05-12
CA1330307C (fr) 1994-06-21

Similar Documents

Publication Publication Date Title
DK644388A (da) Farmaceutiske praeparater indeholdende 3-hydroxy-smoeresyrederivater
NO882732L (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
NO862734L (no) Fremgangsmaate for fremstilling av hyaluronsyreestere.
NO871408D0 (no) Forbedringer ved farmasoeytiske akseptable salter.
DK360988D0 (da) Farmaceutiske cyclodextrinholdige praeparater
NO179359C (no) Fremgangsmåte for fremstilling av farmasöytisk preparat inneholdende somatostatinanaloger.
DE3880667D1 (de) Ampulle zur gesteuerten verabreichung eines heilmittels.
DE3866737D1 (de) Bisphosphonsaeure-derivate und sie enthaltende arzneimittel.
DK642588A (da) Indanderivater, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende samme
DK561089A (da) Anvendelse af lactamimider til fremstilling af laegemidler
ES2018667B3 (es) Derivados del acido 4-qionolon-3-carboxilico, procedimiento para su obtencion y preparados farmaceuticos que los contienen.
NO874850D0 (no) Fremgangsmaate for fremstilling av benzotiadiazinforbindelser og farmasoeytisk akseptable salter derav.
FI883638A7 (fi) Menetelmä haavan paranemista edistävien lääkeainevalmisteiden valmistamiseksi.
DK612788D0 (da) Alkoxyderivater af ginkolider, fremgangsmaade til fremstilling heraf og farmaceutiske praeparater indeholdende saadanne forbindelser
DK561589A (da) Flydende oralt farmaceutisk praeparat
IT8621230A0 (it) Policarbonati ramificati contenenti acidi alifatici policarbossilici o loro derivati e procedimento per la loro preparazione.
DK635988D0 (da) 1,3-butandiolacetoacetat-derivater og anvendelse af 1,3-butandiolacetoacetat-forbindelser til fremstilling af farmaceutiske praeparater
DE69104608D1 (de) Pharmazeutische Zubereitungen, Clavulansäure enthaltend, für die Behandlung der Periodontitis.
IT1228437B (it) "derivati di 2,3,4,5,6,7 esaidro 2,7-metano-1,5 benzossazonina (rispettivamente 1,4 benzossazonina), procedimento per la loro preparazione e prodotti medicinali che contengono questi composti.
ATE137487T1 (de) Komplexe, enthaltend s(+)-phenyl-alkansäuren und alpha-hydroxy-alkansäuren
FI925546A7 (fi) Amidiliittyneitä pyridyylihappojohdannaisia leukotrieeniin liittyvien sairauksien hoitamiseksi
DK229089A (da) Peptid-laegemiddelpraeparater indeholdende alfa-aminoborsyrederivater til indgift via slimhinden
FI881032A7 (fi) Menetelmä N-asetyyli-3 -fluorineuramiinihappojohdannaisten valmistamiseksi.
FI871695A0 (fi) Topiska, kardiovaskulaera produkter.
DK417889A (da) Anvendelse af 2-azabicyklo(2.2.2.)-carboxylsyrederivater til fremstilling af medicinske produkter til behandling af vaskulaere sygdomme

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed